搜索页_+MedDRA

设为首页

收藏本站

网站地图 | English | 公务邮箱

远程访问

NSTL服务站

常用资源

在“Elsevier电子期刊”中，命中：50条，耗时：小于0.01 秒

1.Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment

作者：Robert Dufour^a ; ^{robert.dufour@ircm.qc.ca} ; Jean Bergeron^b ; Daniel Gaudet^c ; Robert Weiss^d ; G. Kees Hovingh^e ; Zhizhi Qing^f ; Feng Yang^g ; Matthew Andisik^g ; Albert Torri^g ; Robert Pordy^g ; Daniel A. Gipe^g

关键词：AE ; adverse event ; Apo ; apolipoprotein ; CVD ; cardiovascular disease ; HDL-C ; high-density lipoprotein cholesterol ; HeFH ; heterozygous familial hypercholesterolemia ; LDL-C ; low-density lipoprotein cholesterol ; Lp(a) ; lipoprotein (a) ; LLT ; lipid-lowering therapy ; MedDRA ; Medical Dictionary for Regulatory Activities ; MI ; myocardial infarction ; PCSK9 ; proprotein convertase subtilisin/kexin type 9 ; Q2W ; every 2 ; weeks ; Q4W ; every 4 ; weeks ; SD ; standard deviation ; TEAE ; treatment-emergent adver

刊名：International Journal of Cardiology

出版年：2017

2.Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies

关键词：AE ; adverse event ; ALT ; alanine aminotransferase ; AST ; aspartate aminotransferase ; DRESS ; drug reaction with eosinophilia and systematic symptoms ; DSMB ; data safety monitoring board ; GGT ; gamma-glutamyl transferase ; GI ; gastrointestinal ; IL-2 ; interleukin 2 ; IM ; intramuscular ; MedDRA ; Medical Dictionary for Regulatory Activities ; MS ; multiple sclerosis ; RRMS ; relapsing-remitting multiple sclerosis ; SAE ; serious adverse event ; SMQ ; Standardised MedDRA Query ; SOC ; System Organ Class ; ULN ; upper li

刊名：Multiple Sclerosis and Related Disorders

出版年：2016

3.A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy

作者：Kiyotaka Yoh ; MD^a ; ^{kyoh@east.ncc.go.jp" class="auth_mail" title="E-mail the corresponding author} ; Yukio Hosomi ; MD PhD^b ; Kazuo Kasahara ; MD PhD^c ; Kazuhiko Yamada ; MD PhD^d ; Toshiaki Takahashi ; MD^e ; Nobuyuki Yamamoto ; MD PhD^f ; Makoto Nishio ; MD PhD^g ; Yuichiro Ohe ; MD PhD^h ; Toshiko Koue ; PhDⁱ ; Takashi Nakamura ; MPHⁱ ; Sotaro Enatsu ; MD PhDⁱ ; Pablo Lee ; MD^j ; David Ferry ; PhD^j ; Tomohide Tamura ; MD^k ; Kazuhiko Nakagawa ; MD PhD^l

关键词：AE ; adverse event ; CI ; confidence interval ; CR ; complete response ; CT ; computed tomography ; DCR ; disease control rate ; ECOG ; Eastern Cooperative Oncology Group ; EGFR ; epidermal growth factor receptor ; FAS ; full analysis set ; HR ; hazard ratio ; ILD ; interstitial lung disease ; IRRC ; Independent Response Review Committee ; MedDRA ; medical dictionary for regulatory activities ; MRI ; magnetic resonance imaging ; NCI-CTCAE ; national cancer institute-common terminology criteria for adverse events ; NSCLC ; n

刊名：Lung Cancer

出版年：2016

4.Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis

作者：Takahiko Saida^a ; ^{Saida_takahiko@maia.eonet.ne.jp" class="auth_mail" title="E-mail the corresponding author} ; Jun-ichi Kira^b ; ^{kira@neuro.med.kyushu-u.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Yasuhiro Ueno^c ; ^{yasuhiro.ueno@biogen.com" class="auth_mail" title="E-mail the corresponding author} ; Naozumi Harada^c ; ^{nysharad@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Toshiyuki Hirakata^c ; ^{toshiyuki.hirakata@biogen.com" class="auth_mail" title="E-mail the corresponding author}

关键词：ARR ; annualized relapse rate ; CI ; confidence interval ; EDSS ; Expanded Disability Status Scores ; Gd+ ; gadolinium-enhancing ; IFN beta ; interferon beta ; IFN beta-1a ; interferon beta-1a ; IM ; intramuscular ; MedDRA ; Medical Dictionary for Regulatory Activities ; MRI ; magnetic resonance imaging ; MS ; multiple sclerosis ; MSCRG ; Multiple Sclerosis Collaborative Research Group ; RRMS ; relapsing remitting multiple sclerosis ; SD ; standard deviation

刊名：Multiple Sclerosis and Related Disorders

出版年：2016

5.OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval

作者：Julien Souvignet^a ; ^b ; ^c ; ^d ; Gunnar Declerck^e ; Hadyl Asfari^a ; ^b ; ^c ; Marie-Christine Jaulent^a ; ^b ; ^c ; Cé ; dric Bousquet^a ; ^b ; ^c ; ^d ; ^{cedric.bousquet@chu-st-etienne.fr" class="auth_mail" title="E-mail the corresponding author}

关键词：Knowledge representation ; Pharmacovigilance ; Biological ontologies ; Terminological reasoning ; Data retrieval

刊名：Journal of Biomedical Informatics

出版年：2016

6.Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy

关键词：Immunotherapy ; PD-1 ; Nivolumab ; Pembrolizumab ; Adverse drug reaction ; Immune-related adverse events

刊名：Cancer Treatment Reviews

出版年：2016

7.Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: Data from international safety surveillance

作者：Amneet Sandhu^a ; ^b ; David Kao^a ; Philip S. Mehler^b ; Mark C.P. Haigney^c ; Mori J. Krantz^a ; ^b ; ^{mkrantz@dhha.org" class="auth_mail" title="E-mail the corresponding author}

关键词：Naloxone ; Cardiovascular disorders

刊名：International Journal of Cardiology

出版年：2016

8.Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System

作者：E. Raschi^a ; E. Poluzzi^a ; A. Koci^a ; I.C. Antonazzo^a ; G. Marchesini^b ; F. De Ponti^a ; ^{fabrizio.deponti@unibo.it" class="auth_mail" title="E-mail the corresponding author}

关键词：Dipeptidyl peptidase-4 inhibitors ; Sitagliptin ; Saxagliptin ; Heart failure ; Drug safety ; Disproportionality ; Spontaneous reporting system ; FAERS

刊名：Nutrition, Metabolism and Cardiovascular Diseases

出版年：2016

9.Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer

作者：Karim Fizazi^a ; ^{karim.fizazi@igr.fr" class="auth_mail" title="E-mail the corresponding author} ; Kim N. Chi^b ; Johann S. de Bono^c ; Leonard G. Gomella^d ; Kurt Miller^e ; Dana E. Rathkopf^f ; Charles J. Ryan^g ; Howard I. Scher^f ; Neal D. Shore^h ; Peter De Porreⁱ ; Anil Londhe^j ; Tracy McGowan^k ; Nonko Pelhivanov^l ; Robert Charnas^m ; Mary B. Toddⁿ ; Bruce Montgomery^o

关键词：Abiraterone acetate ; Adverse events ; Corticosteroids ; Glucocorticoid ; Long term ; Metastatic castration-resistant prostate cancer ; Tolerability

刊名：European Urology

出版年：2016

10.Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms

作者：Cé ; dric Bousquet^a ; ^b ; É ; ric Sadou^a ; Julien Souvignet^a ; ^b ; Marie-Christine Jaulent^a ; Gunnar Declerck^a ; ^{gunnar.declerck@upmc.fr" class="auth_mail}

关键词：MedDRA ; SNOMED-CT ; Ontology ; Terminology ; Semantic reasoning ; Adverse drug reaction

刊名：Journal of Biomedical Informatics

出版年：June 2014

按检索点细分(50)

题名(6)

关键词(21)

文摘(34)

按出版年细分(50)

2027年及以后(6)

2017年(1)

2016年(8)

2015年(3)

2013年(6)

2012年(5)

2011年(2)

2010年(4)

2009年(2)

2008年(2)

2007年(3)

2006年(3)

2005年(2)

2002年(1)

2000年(1)

2000年及以前(1)

地址：北京市海淀区学院路29号邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700